Head and Neck: journal for the sciences and specialities of the head and neck

Journal

Publication Venue For

  • Racial and rural–urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.  44:1563-1575. 2022
  • Factors associated with loss to follow-up after radiation therapy for head and neck cancer.  44:943-951. 2022
  • Impact of preoperative and intraoperative management on outcomes in osteoradionecrosis requiring free flap reconstruction.  44:698-709. 2022
  • Hyperintensity of integrin-targeted fluorescence agent IntegriSense750 accurately predicts flap necrosis compared to Indocyanine green.  44:134-142. 2022
  • Safety of fibula free flap in patients following total knee replacement..  43:585-589. 2021
  • Immediate and partial neural dysfunction after thyroid and parathyroid surgery: Need for recognition, laryngeal exam, and early treatment.  42:3779-3794. 2020
  • Insurance status and head and neck radiotherapy interruption disparities in the Mid-Southern United States.  42:2013-2020. 2020
  • Tracheotomy in the SARS-CoV-2 pandemic.  42:1392-1396. 2020
  • Lymphatic mapping with SPECT-CT for evaluation of contralateral drainage in lateralized oropharyngeal cancers using an awake injection technique.  42:385-393. 2020
  • Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.  41:3924-3932. 2019
  • Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma.  41:3056-3063. 2019
  • Outcomes and cost implications of microvascular reconstructions of the head and neck.  41:930-939. 2019
  • Oral and pharyngeal cancer risk associated with occupational carcinogenic substances: Systematic review.  40:2724-2732. 2018
  • Effect of time to simulation and treatment for patients with oropharyngeal cancer receiving definitive radiotherapy in the era of risk stratification using smoking and human papillomavirus status.  40:687-695. 2018
  • Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.  39:2425-2432. 2017
  • Retraction to: Worst Pattern Of Invasion and occult cervical metastases for oral squamous carcinoma: Update on impact of adjuvant rt for low-stage high-risk oral squamous cancer (Head & Neck, (2017), 10.1002/hed.24754).  39:2142. 2017
  • DNA-PkCS expression in oropharyngeal squamous cell carcinoma: Correlations with human papillomavirus status and recurrence after transoral robotic surgery.  39:206-214. 2017
  • Worst Pattern Of Invasion and occult cervical metastases for oral squamous carcinoma 2017
  • On the horizon: Optical imaging for cutaneous squamous cell carcinoma.  38:E2204-E2213. 2016
  • Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma.  36:1094-1102. 2014
  • Management of invasive well-differentiated thyroid cancer: An American head and neck society consensus statement.  36:1379-1390. 2014
  • Pilot, randomized trial of resistance exercise during radiation therapy for head and neck cancer.  35:1178-1188. 2013
  • Increased likelihood of long-term gastrostomy tube dependence in head and neck cancer survivors without partners.  35:420-425. 2013
  • Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer.  35:381-387. 2013
  • EGFR expression in advanced head and neck cutaneous squamous cell carcinoma.  34:681-686. 2012
  • Depression in patients with head and neck cancer and a functional genetic polymorphism of the serotonin transporter gene.  34:359-364. 2012
  • Gastrostomy tube placement and use in patients with head and neck cancer.  34:422-428. 2012
  • Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.  33:1666-1674. 2011
  • Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer.  33:1551-1556. 2011
  • Utility of CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck.  33:1547-1550. 2011
  • Barriers to early detection and treatment of head and neck squamous cell carcinoma in African American men.  31:1557-1562. 2009
  • Factors associated with quality of life in outpatients with head and neck cancer 6 months after diagnosis.  31:1207-1214. 2009
  • Exercise preferences among patients with head and neck cancer: Prevalence and associations with quality of life, symptom severity, depression, and rural residence.  31:994-1005. 2009
  • Cancer of the tonsil presenting as central nervous system metastasis: A case report.  31:127-130. 2009
  • Factors associated with fatigue, sleep, and cognitive function among patients with head and neck cancer.  30:1310-1317. 2008
  • Zygomaticomaxillary buttress reconstruction of midface defects with the osteocutaneous radial forearm free flap.  30:1295-1302. 2008
  • Evolution of a paradigm for free tissue transfer reconstruction of lateral temporal bone defects.  30:589-594. 2008
  • Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck.  30:281-288. 2008
  • Driving behaviors in patients with head and neck cancer during and after cancer treatment: A preliminary report.  29:675-681. 2007
  • Muscle-sparing abdominal free flaps in head and neck reconstruction.  28:802-807. 2006
  • Pattern of nonspecific (or global) DNA methylation in oral carcinogenesis.  27:1061-1067. 2005
  • Use of negative pressure dressings in head and neck reconstruction.  27:970-975. 2005
  • Simplifying head and neck microvascular reconstruction.  26:930-936. 2004
  • Malignant carotid body tumor.  26:301-306. 2004
  • Intraoperative radiotherapy for head and neck and skull base cancer.  25:217-226. 2003
  • Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer.  25:118-122. 2003
  • The pattern of expression of Mn and Cu-Zn superoxide dismutase varies among squamous cell cancers of the lung, larynx, and oral cavity.  24:859-867. 2002
  • Head and neck: Editorial.  23:1021-1023. 2001
  • Head and neck: Letter to the editor [1] (multiple letters).  23:1079. 2001
  • Malt lymphoma presenting as a cystic salivary gland mass.  23:254-258. 2001
  • MALT lymphoma presenting as a cystic salivary gland mass..  23:254-258. 2001
  • Ischemia/reperfusion injury in microvascular surgery.  22:700-713. 2000
  • Transforming growth factor α (TGF-α) expression in dysplastic oral leukoplakia: Modulation by 13-cis retinoic acid.  21:566-573. 1999
  • Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue.  21:325-329. 1999
  • The pathogenesis of vascular thrombosis and its impact in microvascular surgery.  21:355-362. 1999
  • T1 and t2 squamous cell carcinoma of the oral tongue: Prognostic factors and the role of elective lymph node dissection.  21:124-130. 1999
  • Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer?.  19:692-700. 1997
  • Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer?.  19:692-700. 1997
  • Effects of implantable biomaterials on radiation dosimetry.  19:384-390. 1997
  • Aneurysmal bone cyst to the editor.  17:358-359. 1995
  • Prognostic factors in minor salivary gland cancer.  17:480-486. 1995
  • Analysis of recurrence, complications, and functional results with free jejunal flaps.  16:149-154. 1994
  • Aneurysmal bone cyst of the zygomatic arch.  16:594-597. 1994
  • Olfactory neuroblastoma: The results of modern treatment approaches at the University of Michigan.  15:190-196. 1993
  • Flow cytometric analysis of DNA ploidy in lymphomas of the thyroid.  10:324-329. 1988
  • Malignant salivary tumors—analysis of prognostic factors and survival.  9:82-92. 1986
  • Surgical treatment of early‐stage carcinoma of the oral tongue—would adjuvant treatment be beneficial?.  8:401-408. 1986
  • International Standard Serial Number (issn)

  • 0148-6403
  • 1043-3074
  • Electronic International Standard Serial Number (eissn)

  • 1097-0347
  • 1930-2398